[Monitoring of the results of the treatment of chorionic carcinoma (author's transl)].
Because of the high sensitivity and specificity of the method, radio-immunologic determination of the Beta Subunit HCG in the serum is superior to other methods of monitoring the therapeutic results of the treatment of chorionic carcinoma. A ratio of 225 to 1 of HCG concentrations in the serum versus the cerebral spinal fluid is evidence against the probability of a metastasis of chorionic carcinoma in the central nervous system. Following successful treatment of chorionic carcinoma it is advisable to determine the serum HCG with the Beta Subunit method weekly during the first two months and montly in the succeeding two years and thereafter at three months intervals.
D000328:Adult; D002822:Choriocarcinoma / Q000188:drug therapy / Q000652:urine*; D006063:Chorionic Gonadotropin / Q000134:cerebrospinal fluid / Q000652:urine; D005260:Female; D006801:Humans; D011247:Pregnancy; D011863:Radioimmunoassay; D012075:Remission, Spontaneous; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000652:urine*
D006063:Chorionic Gonadotropin
Therapiekontrolle beim Chorionepitheliom.